Article
Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients.
Annals of the rheumatic diseases - 1 Jan 2011
Coulthard Lydia R, Taylor John C, Eyre Steve, Robinson James I, Wilson Anthony G, Isaacs John D, Hyrich Kimme, Emery Paul, Barton Anne, Barrett Jennifer H, Morgan Ann W, McDermott Michael F
Abstract excerpt
BACKGROUND: Rheumatoid arthritis (RA) does not always respond to available treatments, including tumour necrosis factor (TNF) antagonists. A study was undertaken to investigate whether genetic variation within genes, encoding proteins in the p38 signalling network, contributes to the variable response to TNF antagonists. METHODS: 1102 UK Caucasian patients with RA receiving anti-TNF therapy (infliximab,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
